Norwalk Leslie V
SEC Form 4 insider trading activity
Norwalk Leslie V has filed 10 SEC Form 4 filings (14 transaction rows) across 4 companies, including NBIX, ARVN, CVS, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Jul 30, 2026.
On the most recent filing, Norwalk Leslie V is listed as Director at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, Norwalk Leslie V reported no open-market purchases and 7 open-market sales totaling $2.5M in NBIX and GMED. The largest disclosed transaction in the window is a sale of 5,000 NBIX shares on Dec 15, 2025, worth $761K.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
4
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Norwalk Leslie V made?
Norwalk Leslie V has filed 10 SEC Form 4 filings (14 transaction rows) across 4 companies, including NBIX, ARVN, CVS since 2025.
Which companies does Norwalk Leslie V trade?
Norwalk Leslie V has filed SEC Form 4 disclosures for 4 companies, including NBIX, ARVN, CVS.
When was Norwalk Leslie V's most recent SEC Form 4 filing?
Norwalk Leslie V's most recent SEC Form 4 filing on Tracefour is dated Jul 30, 2026.
What is Norwalk Leslie V's total buy and sell value in the current window?
Inside the rolling retention window, Norwalk Leslie V bought $0 and sold $2.5M based on SEC Form 4 filings.
What was Norwalk Leslie V's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 NBIX shares on 2025-12-15, worth $761K, per SEC Form 4 filings.